货号:GS40168
Dargistotug (M-6223) is an investigational fully human IgG1 monoclonal antibody designed as an immune checkpoint inhibitor for the treatment of cancer. It specifically targets TIGIT (T cell immunoreceptor with Ig and ITIM domains), an inhibitory receptor expressed on T cells and NK cells. By blocking TIGIT, it aims to restore anti-tumor immunity and is being evaluated in clinical trials, often in combination with other immunotherapies like PD-1/PD-L1 inhibitors, for various advanced solid tumors.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
冉凯凯